JP2004509076A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509076A5
JP2004509076A5 JP2002512129A JP2002512129A JP2004509076A5 JP 2004509076 A5 JP2004509076 A5 JP 2004509076A5 JP 2002512129 A JP2002512129 A JP 2002512129A JP 2002512129 A JP2002512129 A JP 2002512129A JP 2004509076 A5 JP2004509076 A5 JP 2004509076A5
Authority
JP
Japan
Prior art keywords
mmol
biphenyl
pyrrolidinylcarbamate
aminopyrrolidinyl
carbonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002512129A
Other languages
English (en)
Japanese (ja)
Other versions
JP4516717B2 (ja
JP2004509076A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/021929 external-priority patent/WO2002006223A1/en
Publication of JP2004509076A publication Critical patent/JP2004509076A/ja
Publication of JP2004509076A5 publication Critical patent/JP2004509076A5/ja
Application granted granted Critical
Publication of JP4516717B2 publication Critical patent/JP4516717B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002512129A 2000-07-13 2001-07-11 ヒスタミン−3受容体リガンドとしての1,3−二置換ピロリジン及び1,3,3−三置換ピロリジン並びにそれらの治療的応用 Expired - Fee Related JP4516717B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61515100A 2000-07-13 2000-07-13
PCT/US2001/021929 WO2002006223A1 (en) 2000-07-13 2001-07-11 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications

Publications (3)

Publication Number Publication Date
JP2004509076A JP2004509076A (ja) 2004-03-25
JP2004509076A5 true JP2004509076A5 (enExample) 2009-09-24
JP4516717B2 JP4516717B2 (ja) 2010-08-04

Family

ID=24464202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002512129A Expired - Fee Related JP4516717B2 (ja) 2000-07-13 2001-07-11 ヒスタミン−3受容体リガンドとしての1,3−二置換ピロリジン及び1,3,3−三置換ピロリジン並びにそれらの治療的応用

Country Status (15)

Country Link
EP (1) EP1301480B1 (enExample)
JP (1) JP4516717B2 (enExample)
AR (1) AR030939A1 (enExample)
AT (1) ATE372981T1 (enExample)
AU (1) AU2001273384A1 (enExample)
BR (1) BR0108088A (enExample)
CA (1) CA2415396C (enExample)
CY (1) CY1107815T1 (enExample)
DE (1) DE60130460T2 (enExample)
DK (1) DK1301480T3 (enExample)
ES (1) ES2292603T3 (enExample)
MX (1) MXPA02012851A (enExample)
PE (1) PE20020191A1 (enExample)
PT (1) PT1301480E (enExample)
WO (1) WO2002006223A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620839B2 (en) * 2000-07-13 2003-09-16 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
US6316475B1 (en) * 2000-11-17 2001-11-13 Abbott Laboratories Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications
JP4619655B2 (ja) 2001-09-14 2011-01-26 ハイ・ポイント・ファーマスーティカルズ、エルエルシー 新規アミノアゼチジン、−ピロリジンおよび−ピペリジン誘導体
US6673829B2 (en) 2001-09-14 2004-01-06 Novo Nordisk A/S Aminoazetidine,-pyrrolidine and -piperidine derivatives
US7314937B2 (en) 2002-03-21 2008-01-01 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
GB0224084D0 (en) * 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0308333D0 (en) * 2003-04-10 2003-05-14 Glaxo Group Ltd Novel compounds
US7595316B2 (en) 2003-06-27 2009-09-29 Banyu Pharmaceutical Co., Ltd. Heteroaryloxy nitrogenous saturated heterocyclic derivative
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7456164B2 (en) 2004-05-07 2008-11-25 Pfizer, Inc 3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
AP2353A (en) * 2004-05-07 2012-02-16 Warner Lambert Co 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands.
EP1593679A1 (en) * 2004-05-07 2005-11-09 Warner-Lambert Company LLC 3- Or 4-monosubstituted phenol derivatives useful as H3 ligands
EP1595881A1 (en) 2004-05-12 2005-11-16 Pfizer Limited Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
WO2006059778A1 (ja) * 2004-12-01 2006-06-08 Banyu Pharmaceutical Co., Ltd. 置換ピリドン誘導体
GB0514811D0 (en) * 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
GB0514812D0 (en) * 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
US7728031B2 (en) 2006-02-24 2010-06-01 Abbott Laboratories Octahydro-pyrrolo[3,4-b]pyrrole derivatives
CN101809021B (zh) 2007-09-11 2013-04-24 雅培制药有限公司 八氢-吡咯并[3,4-b]吡咯n-氧化物
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3522790B2 (ja) * 1993-06-08 2004-04-26 花王株式会社 H3−レセプター刺激薬
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
WO1996032937A1 (en) * 1995-04-21 1996-10-24 Eli Lilly And Company Benzothiophenes with novel basic side chains
AU3176297A (en) * 1996-06-25 1998-01-14 Novartis Ag Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
EP0978512A1 (en) * 1998-07-29 2000-02-09 Societe Civile Bioprojet Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications

Similar Documents

Publication Publication Date Title
US20100274027A1 (en) Organic compounds
US20240336603A1 (en) Process for the preparation of a cyp11a1 inhibitor and intermediates thereof
JP3226100B2 (ja) 抗腫瘍剤としてのアリールスルホニルイミダゾロン誘導体
US20250197440A1 (en) Process for the preparation of a cyclic dinucleotide
JP2003534332A5 (enExample)
US7501423B2 (en) Tubulin inhibitor and process for its preparation
WO2008131582A1 (en) The method for making candixatan ester and intermediates thereof
WO2012004811A1 (en) Process for the preparation of 5-substsituted indole derivative
WO2017144015A1 (zh) 一种新毒素及其中间体的制备方法
CN111233921A (zh) 新化合物及其用于合成磷霉素杂质d的方法
KR100708581B1 (ko) 리토나비르의 합성 방법
US7345179B2 (en) Process for producing pyrrolidine derivative
CA2431821C (en) Method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones
CN1982301B (zh) 2',2'-二氟核苷及其中间体的制备方法
EP1891052A1 (en) Tubulin inhibitor and process for its preparation
KR102152445B1 (ko) 의약품 합성용 중간체 화합물의 제조 방법
KR100450607B1 (ko) 가라민 유도체의 제조방법
JP2009221122A (ja) 蛍光誘導体の製造方法
US20120022273A1 (en) Process for the preparation of (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin useful for their applications in therapeutics as anticancer agent
CN113072466A (zh) 达泊西汀杂质的合成方法
KR20030055304A (ko) 보호된 1-(1-아미노알킬)-옥시란의 제조 방법
EP0987273A1 (en) Process for preparing antifungal v-28-3m
JP2010105943A (ja) 5−{4−[2−(5−エチル−2−ピリジル)エトキシ]ベンジル}−2,4−チアゾリジンジオン塩酸塩の製造方法
FR2575470A1 (fr) Derives amines de n-imidazolylmethyl-diphenylazomethines, leur preparation et leur application en therapeutique
JPWO1998055492A1 (ja) 抗真菌剤v−28−3mの製造方法